Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective

OBJECTIVES: The objective of this study was to evaluate a US hospital’s cost implications and outcomes of cangrelor use in percutaneous coronary intervention (PCI) patients with two or more angiographic high-risk features (HRFs), including avoidance of oral P2Y(12) inhibitor pretreatment in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Jensen, Ivar S., Wu, Elizabeth, Cyr, Philip L., Claussen, Marc, Winkler, Thomas, Salahuddin, Khalid, Prats, Jayne, Mahaffey, Kenneth W., Gibson, Charles Michael, Steg, Philippe Gabriel, Stone, Gregg W., Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748330/
https://www.ncbi.nlm.nih.gov/pubmed/34331235
http://dx.doi.org/10.1007/s40256-021-00491-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748330/
https://www.ncbi.nlm.nih.gov/pubmed/34331235
http://dx.doi.org/10.1007/s40256-021-00491-9

Ejemplares similares